Clinical Trial Update: Effect of Metformin on Frailty in 12 Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating metformin for frailty in older adults was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Frailty
• Inflammation

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Mayo Clinic | Conditions: Aging, Inflammation | Phase 2 | Status: TERMINATED | Results posted: 2022-11-17